Semaglutide, a glucagon-like peptide-1 receptor agonist, is a candidate for the treatment of metabolic dysfunction–associated steatohepatitis (MASH). In this ongoing phase 3, multicenter, randomized, ...
In a multicenter randomized trial of 150 children and adolescents, trigeminal nerve stimulation failed to outperform sham ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback